Education
Quick Search | |||||||||||
| |||||||||||
View Track: Luncheon Presentations | |||||||||||
| Luncheon Presentations | |||||||||||
| Tuesday, March 29, 2011 | |||||||||||
 | |||||||||||
Presented by: Cell Therapies hold the promise of improving the quality and ultimately the lifespan of patients stricken with some of the world’s most challenging diseases and medical conditions. Manufacturers have the unique advantage of learning from the successes (and failures) of protein-based manufacturers – which could ultimately shave off years from their development and manufacturing timetables.  Based upon BioProcess International’s March 2011 Supplement, this groundbreaking roundtable will: • Educate the bioprocess and cell therapy market (suppliers and end-users) on the similarities and differences between the two processes; • Educate and encourage the investor community to keep increasing their interest and investment; • Expedite the commercialization process. ***Open to Full and One Day Tuesday Conferees, Designated exhibitors and Speakers. Ticket required. Speaker: Dominic Clarke - Product Manager, Stem-Cell Freezing, Charter Medical Robert Perry, Athersys Robert Preti - President & CSO, Progenitor Cell Therapy, LLC Jon Rowley, Lonza Moderator:Anne Montgomery - Editor in Chief, BioProcess International Bob Speziale - Vice President, Business Development, Invetech | |||||||||||
| Wednesday, March 30, 2011 | |||||||||||
| |||||||||||
Presented by: As the need for new generations of vaccines are needed to battle a new generation of threats, the world looks to the biotechnology industry to increase both speed of production and specificity of vaccines. Increased understanding of human immunology combined with new technologies, production platforms and process innovations provide vaccine developers with access to proven options unknown to previous generations. A preview to BioProcess International’s September 2011 supplement, this roundtable will: • Recap the history of vaccines • Discuss the need to balance philanthropy and profitability • Introduce the latest technological innovations and challenges • Preview the continuing work towards pandemic preparedness ***Open to Full and One Day Wednesday Conferees, Designated exhibitors and Speakers. Ticket required. Speaker: Vikas Gupta, Merck Peter Latham - Co-Founder, President, BioPharm Services US Magda Marquet, Althea Technologies James Wilkins - Chief Technology Officer, Sensorin Moderator:Anne Montgomery - Editor in Chief, BioProcess International | |||||||||||
| |||||||||||